Insider · CIK 0001507678
Pablo G. Legorreta
ceochairofficerdirectorowner
Files at RPRX (Royalty Pharma plc), PROK (PROKIDNEY CORP.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 5, 2025 | RPRX Royalty Pharma plc | AGrant or award Class A Ordinary Shares | +36,559 | $0.00 | $0 | 940,955 | Nov 7, 2025 |
| Aug 6, 2025 | RPRX Royalty Pharma plc | AGrant or award Class A Ordinary Shares | +21,901 | $0.00 | $0 | 904,396 | Aug 8, 2025 |
| Aug 8, 2025 | RPRX Royalty Pharma plc | GGift LP interests in RPI US Partners 2019, LPderivative | -60,000 | $0.00 | $0 | 692,701 | Aug 8, 2025 |
| Jun 3, 2025 | PROK PROKIDNEY CORP. | CConversion Class A Ordinary Sharesindirect: See footnote | +3,823,996 | $0.00 | $0 | 26,441,905 | Jun 5, 2025 |
| Jun 3, 2025 | PROK PROKIDNEY CORP. | JOther Class A Ordinary Sharesindirect: See footnote | -3,823,996 | $0.00 | $0 | 22,617,909 | Jun 5, 2025 |
| Jun 3, 2025 | PROK PROKIDNEY CORP. | CConversion Class B Ordinary Sharesderivativeindirect: See footnote | -3,823,996 | $0.00 | $0 | 84,283,430 | Jun 5, 2025 |
| Jun 3, 2025 | PROK PROKIDNEY CORP. | CConversion Common Units in ProKidney LPderivativeindirect: See footnote | -3,823,996 | $0.00 | $0 | 84,283,430 | Jun 5, 2025 |
| May 29, 2025 | PROK PROKIDNEY CORP. | AGrant or award Director stock option (right to buy)derivative | +125,862 | $0.00 | $0 | 125,862 | Jun 2, 2025 |
| May 16, 2025 | RPRX Royalty Pharma plc | JOther Class A Ordinary Shares | +530,348 | $0.00 | $0 | 882,495 | May 20, 2025 |
| May 16, 2025 | RPRX Royalty Pharma plc | AGrant or award Class E Ordinary Sharesderivativeindirect: By PL RPH Holdings, LLC | +13,356,742 | $0.00 | $0 | 13,356,742 | May 20, 2025 |
| May 16, 2025 | RPRX Royalty Pharma plc | JOther Option (Right to Buy)derivativeindirect: By PL RPH Holdings, LLC | +857,138 | $0.00 | $0 | 857,138 | May 20, 2025 |
| May 12, 2025 | RPRX Royalty Pharma plc | GGift Class B Ordinary Sharesderivativeindirect: By Spouse | -867,180 | $0.00 | $0 | 0 | May 14, 2025 |
| May 12, 2025 | RPRX Royalty Pharma plc | GGift Class B Ordinary Sharesderivative | +867,180 | $0.00 | $0 | 0 | May 14, 2025 |
| May 8, 2025 | RPRX Royalty Pharma plc | AGrant or award Class A Ordinary Shares | +288,352 | $0.00 | $0 | 352,147 | May 9, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.